CONVERSION THERAPY
Clinical trials for CONVERSION THERAPY explained in plain language.
Never miss a new study
Get alerted when new CONVERSION THERAPY trials appear
Sign up with your email to follow new studies for CONVERSION THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple therapy aims to turn inoperable lung cancer into a surgical target
Disease control Not yet recruitingThis study tests whether combining an immunotherapy drug (tislelizumab) with standard chemotherapy and a targeted artery treatment can shrink stage III lung cancer that cannot be removed by surgery. About 39 adults with newly diagnosed, unresectable non-small cell lung cancer wil…
Matched conditions: CONVERSION THERAPY
Phase: PHASE2 • Sponsor: Sichuan Cancer Hospital and Research Institute • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New tool could guide surgery decisions for tough liver cancer
Knowledge-focused Not yet recruitingThis study looks at 270 people with a type of liver cancer (intrahepatic cholangiocarcinoma) that cannot be removed right away. After initial chemotherapy, doctors will use a special evaluation system (TDTP-RECIST) to decide whether to continue medication or perform surgery. The …
Matched conditions: CONVERSION THERAPY
Phase: NA • Sponsor: Shanghai Zhongshan Hospital • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC